Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ligand Pharmaceuticals Inc (LGND)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Dorset Management

David M. Knott

998,100 $101,866 -17% 52.58%
2.
Cardinal Capital

Amy Minella

673,850 $68,773 +1% 3.18%
3.
Blue Clay Capital

Adam Wright And Gary Kohler

17,125 $1,748 +7% 1.97%
4.
CQS Cayman LPBOND

Michael Hintze

12,000,000 $17,562 1.47%
5.
Highbridge Capital ManagementBOND

Glenn Russell Dubin

25,000,000 $36,611 0.57%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaning Holdings Date Form 4
$45.23 126 Officer 27,433 2014-12-31 Filing
$45.23 46 Officer 55,016 2014-12-31 Filing
$45.23 103 Officer 2,831 2014-12-31 Filing
$45.68 2,000 Director 49,286 2014-10-15 Filing
$44.91 85 Officer 53,970 2014-10-10 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$106.96 3,478 Director 185,898 2016-11-25 Filing
$107.40 15,001 Director 189,376 2016-11-22 Filing
$105.00 5,000 Director 204,377 2016-11-18 Filing
$106.33 1,330 Director 209,377 2016-11-16 Filing
$117.34 3,000 Officer, Director 122,664 2016-09-22 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 181,383 $18,512 3.59%
2. 43,174 $4,406 3.03%
3. 71,562 $7,304 2.9%
4. 149,422 $15,250 2.49%
5. 339,467 $34,646 2.37%
News See All